You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LXEO Award Disclosure
Bhalla Narinder Pal · SEC Form 4 · Filed Jul 1, 2026
Award
Calculated transaction value
$0
Bhalla Narinder Pal Chief Medical Officer
LXEO
Lexeo Therapeutics
LXEO
Transaction date
Jun 29, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed 2 days later
LXEO daily price context
Close on/before transaction
$4.81
Jun 29, 2026
First close after public filing
$4.69
Jul 2, 2026
30-day return after filing
-11.94%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 55,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002109299-26-000007
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$98.59K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lexeo Therapeutics, Inc. LXEO | Sale | Jul 1, 2026 | $98.59K |
| Lexeo Therapeutics, Inc. LXEO Current | Award | Jun 29, 2026 | $0 |